Later stage funding
For later stage funding, below are some of the VC with a focus on the following:
Scottish Equity Partners
Scottish Equity Partners (SEP) invest in innovative high growth companies with world class potential across the technology, healthcare and energy sectors. As well as primary venture capital funds, SEP also manages secondary and infrastructure finance funds with a specific focus on energy. Their high calibre team is one of the most experienced in Europe and has been helping great companies to achieve incredible things for over 20 years.
Elsevier is a world-leading provider of information solutions that help you make better decisions, deliver better care, and sometimes make groundbreaking discoveries in science, health, and technology. Elsevier provide web-based, digital solutions — among them ScienceDirect, Scopus, Evolve, Knovel, Reaxys and ClinicalKey — and publish over 2,500 journals and more than 33,000 book titles.
Albion Ventures was established to generate long term investment returns for shareholders through making venture capital investments in smaller companies. Albion Ventures enjoys working with smaller companies and entrepreneurial management teams, seeing their purpose as helping businesses to grow by providing financial resources as well as strategic advice. Their ultimate aim is to realise the full potential of the business invested in and so create returns for the shareholders in their funds.
Dr. Vishal Gulati
Dr. Vishal Gulati is one of the Europe’s leading digital healthcare investors. Vishal is a qualified physician and chairman of the Digital Health Forum. Over the last decade he has championed deals across areas including diagnostics, devices & biotech. He is currently on the boards of Horizon Discovery PLC and EcoEos. His investments include Napo Pharmaceuticals, Glenmark, Renovo, Phagenesis. He has also held board positions at Psynova Neurotech, Bioscale and Enigma Diagnostics. Previously, Vishal worked at Atlas Venture, The Wellcome Trust and Radiant Capital.